Dare Bioscience Inc

DARE

Company Profile

  • Business description

    Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women’s health.

  • Contact

    3655 Nobel Drive
    Suite 260
    San DiegoCA92122
    USA

    T: +1 858 926-7655

    E: [email protected]

    https://www.darebioscience.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    23

Stocks News & Analysis

stocks

Magellan merger modestly dilutive

Our view on how shareholders should respond to the Magellan merger.
stocks

ASX listed gold miner under pressure due to lower production

Shares have dropped nearly 20% since lowering 2026 volume guidance.
stocks

3 ASX opportunities after earnings season

Uncovering key opportunities following February’s results.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,847.7014.200.16%
CAC 407,974.4938.520.49%
DAX 4023,730.92166.910.71%
Dow JONES (US)46,993.2646.850.10%
FTSE 10010,403.6085.910.83%
HKSE25,995.95127.410.49%
NASDAQ22,479.53105.350.47%
Nikkei 22555,239.401,539.012.87%
NZX 50 Index13,315.60133.371.01%
S&P 5006,716.0916.710.25%
S&P/ASX 2008,640.6014.400.17%
SSE Composite Index4,062.9813.080.32%

Market Movers